Melanotan1 Research Overview and Analytical Profile
Melanotan1 (also designated as [Nle4, D-Phe7]-α-MSH or Afamelanotide) is a synthetic peptide analog of endogenous alpha-melanocyte-stimulating hormone (α-MSH). In preclinical research settings, melanotan1 functions as a potent melanocortin receptor agonist, primarily evaluated in cell culture systems and animal models to investigate melanocortin-1 receptor (MC1R) binding kinetics, intracellular cyclic AMP signaling pathways, and downstream skin pigmentation responses.
Quick answer
Melanotan1 (also designated as [Nle4, D-Phe7]-α-MSH or Afamelanotide) is a synthetic peptide analog of endogenous alpha-melanocyte-stimulating hormone (α-MSH). In preclinical research settings, melanotan1 functions as a potent melanocortin receptor agonist, primarily evaluated in cell culture systems and animal models to investigate melanocortin-1 receptor (MC1R) binding kinetics, intracellular cyclic AMP signaling pathways, and downstream skin pigmentation responses.
Key takeaways
- Melanotan1 is a linear synthetic tridecapeptide with the amino acid sequence Ac-Ser-Tyr-Ser-Met-Glu-His-DPhe-Arg-Trp-Gly-Lys-Pro-Val-NH2.
- In vitro functional assays demonstrate that melanotan1 binds with high affinity to the melanocortin-1 receptor (MC1R), a G-protein coupled receptor (GPCR) expressed predominantly on epidermal melanocyte membranes.
- The scientific literature documenting melanotan1 spans several decades of preclinical investigation centered on melanogenesis and cellular stress responses.
- Evaluating melanotan1 within the context of related melanocortin analogs helps researchers select the appropriate compound for specific experimental targets.
Chemical Structure and Molecular Definition of Melanotan1
Melanotan1 is a linear synthetic tridecapeptide with the amino acid sequence Ac-Ser-Tyr-Ser-Met-Glu-His-DPhe-Arg-Trp-Gly-Lys-Pro-Val-NH2. It represents a structurally modified derivative of native alpha-melanocyte-stimulating hormone (α-MSH). By substituting specific residues within the native sequence—specifically replacing Met4 with Norleucine (Nle4) and L-Phe7 with D-Phenylalanine (D-Phe7)—chemists created a peptide structure exhibiting significantly higher enzymatic resistance against central and peripheral peptidases. This structural refinement increases the molecule's half-life in analytical assays compared to wild-type α-MSH.
As a primary class representative of melanocortin agonists, melanotan1 exhibits high affinity for melanocortin receptors across multiple mammalian species. Researchers interested in deep architectural analyses of peptide structures can reference our comprehensive overview in the melanotan-1 research intelligence guide. For verified reference materials suitable for in vitro assays, PX1 Research provides high-purity melanotan-1 product listings manufactured under strict analytical quality control standards.
Receptor Affinity and Preclinical Mechanism of Action
In vitro functional assays demonstrate that melanotan1 binds with high affinity to the melanocortin-1 receptor (MC1R), a G-protein coupled receptor (GPCR) expressed predominantly on epidermal melanocyte membranes. Receptor binding triggers conformational changes that activate membrane-bound adenylyl cyclase, leading to an intracellular accumulation of cyclic adenosine monophosphate (cAMP). This secondary messenger cascade downstream stimulates protein kinase A (PKA), resulting in the phosphorylation and activation of the microphthalmia-associated transcription factor (MITF).
Preclinical studies suggest that elevated MITF activity upregulates the transcription of essential melanogenic enzymes, specifically tyrosinase, tyrosinase-related protein 1 (TYRP1), and dopachrome tautomerase (DCT/TYRP2). In vitro assays conducted on isolated melanocyte cell cultures indicate that activation of this enzymic cascade shifts the enzymatic balance toward the synthesis of dark, photoprotective eumelanin rather than the lighter pheomelanin pigment. Additional preclinical research models demonstrate variable cross-reactivity with peripheral MC3R, MC4R, and MC5R targets, providing valuable baseline data for signaling selectivity studies across the broader melanocortin receptor family.
Preclinical Literature on Skin Pigmentation Responses
The scientific literature documenting melanotan1 spans several decades of preclinical investigation centered on melanogenesis and cellular stress responses. In murine models and human skin explant cultures, administration of melanotan1 accelerates the accumulation of melanin granules within dermal layers independently of initial ultraviolet radiation exposure. Researchers utilize these models to quantify the rate of pigment dispersion, cellular proliferation parameters, and baseline DNA repair marker expression in response to environmental stressors.
In vitro assays further indicate that MC1R activation by melanotan1 may modulate cellular antioxidant defenses. Preclinical evidence suggests that elevated intracellular cAMP levels via MC1R signaling decrease the generation of reactive oxygen species (ROS) in UV-irradiated cell cultures. Laboratory researchers evaluating photo-damage mechanisms often incorporate melanotan1 into experimental protocols alongside control baseline reagents selected from our catalog of all research peptides to measure cellular viability, oxidative stress markers, and gene expression changes under controlled laboratory conditions.
Comparative Analysis: Melanotan 1 vs. Related Melanocortin Receptor Agonists
Evaluating melanotan1 within the context of related melanocortin analogs helps researchers select the appropriate compound for specific experimental targets. The melanocortin system comprises multiple peptide variants engineered to probe distinct receptor subtype affinities and physiological pathways.
While melanotan1 maintains a linear structure with high selectivity toward MC1R, its cyclic derivative melanotan-2 exhibits enhanced lipophilicity and reduced receptor selectivity. Melanotan II demonstrates marked cross-reactivity with central MC3R and MC4R subtypes, altering central nervous system signaling pathways in animal models. Similarly, the synthetic analog PT-141 research compound (bremelanotide) targets central MC3R and MC4R pathways to investigate neurological and vascular responses without promoting melanogenesis in skin tissue models. Native α-MSH serves as an endogenous benchmark, though its rapid enzymatic degradation limits its utility in extended benchtop assays compared to stable synthetic variants like melanotan1.
Analytical Verification: RP-HPLC and Mass Spectrometry
Maintaining rigorous chemical standards is essential for reproducible scientific outcomes. PX1 Research subjects every lot of melanotan1 to comprehensive analytical testing using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS). RP-HPLC analysis verifies that the peptide achieves a chemical purity threshold of at least 98.0%, ensuring that related sequence impurities, truncated peptides, or chemical adducts do not interfere with downstream cellular assays.
Mass spectrometry confirms the precise molecular weight and identity of the synthesized peptide, confirming structural integrity across single batch runs. Every shipment includes a lot-specific Certificate of Analysis (COA) detailing the exact retention time, peak area percentages, and mass spectral confirmation. Principal investigators seeking robust datasets can access complete batch documentation through our centralized research intelligence hub.
Endotoxin Testing and Quality Standards
Bacterial endotoxins (lipopolysaccharides) pose a significant risk to cell culture viability and downstream preclinical experimentation. Inadvertent endotoxin contamination can trigger non-specific inflammatory signaling pathways, skewing receptor binding kinetics, cytokine expression, and cell mortality measurements. To eliminate this experimental variable, PX1 Research evaluates melanotan1 lots using chromogenic Limulus Amebocyte Lysate (LAL) assays.
All lots delivered to academic and commercial institutions meet stringent endotoxin thresholds (<0.01 EU/μg), ensuring suitability for sensitive cell culture and biochemical applications. Testing is performed in ISO 17025 accredited analytical laboratories operating within GMP-compliant environments. This commitment to analytical precision ensures that laboratory data generated using PX1 Research materials remain consistent, reproducible, and robust.
Reconstitution and Laboratory Storage Protocols
Proper handling and storage of lyophilized melanotan1 are vital to prevent degradation, hydrolysis, or aggregation prior to experimental use. Upon arrival, the lyophilizate should be stored in a freezer at -20°C or -80°C, protected from light and moisture. Lyophilized vials stored under these conditions remain chemically stable for extended research timelines.
When preparing solutions for laboratory assays, researchers should perform reconstitution under a sterile laminar flow hood. Allow the vial to equilibrate to room temperature before adding a sterile laboratory solvent, such as bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4). Gentle rotation of the vial facilitates dissolution; mechanical vortexing or vigorous shaking must be avoided to prevent protein shearing and aggregation. Once reconstituted, stock solutions should be aliquoted into single-use microcentrifuge tubes to prevent repeated freeze-thaw cycles and maintained at 4°C for short-term experimentation (up to 7 days) or -20°C for longer storage intervals.
Supply Chain Integrity and Domestic Manufacturing
Reliable experimental workflows depend on uninterrupted material supply and guaranteed product quality. PX1 Research synthesizes all peptide compounds in state-of-the-art USA facilities adhering to strict quality control protocols. By managing the supply chain domestically, we avoid the quality degradation, batch variability, and shipping delays frequently associated with unverified overseas sourcing.
Orders are fulfilled directly from strategic distribution hubs located in California and Arizona, offering same-day shipping for orders placed Monday through Friday prior to cut-off times. Academic laboratories, biotech institutions, and independent research facilities requiring scalable procurement can establish verified institutional access through our wholesale lab portal.
Frequently Asked Questions
What is melanotan1 in laboratory research?
Melanotan1 ([Nle4, D-Phe7]-α-MSH) is a synthetic, enzymatic-resistant tridecapeptide analog of endogenous alpha-melanocyte-stimulating hormone. In laboratory research, it is utilized to study melanocortin-1 receptor (MC1R) binding, intracellular cAMP signaling, and melanogenesis in cell culture and animal models.
What primary receptor target is associated with melanotan1?
Melanotan1 demonstrates primary high-affinity binding to the melanocortin-1 receptor (MC1R) on melanocytes, while showing secondary cross-reactivity with peripheral MC3R, MC4R, and MC5R subtypes in comparative preclinical assays.
How is melanotan1 chemical purity verified?
Purity is verified via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to confirm purity levels of ≥98.0%, paired with Mass Spectrometry (ESI-MS) to verify exact molecular mass and structural identity.
What are the endotoxin limits for melanotan1 from PX1 Research?
PX1 Research subjects every batch to chromogenic LAL assays to ensure endotoxin levels remain below 0.01 EU/μg, preventing non-specific immune signaling or cell culture toxicity.
How should lyophilized melanotan1 be stored in the lab?
Lyophilized melanotan1 should be stored at -20°C or -80°C in a dry environment protected from direct light exposure. Avoid repeated temperature fluctuations prior to reconstitution.
What is the recommended reconstitution procedure for melanotan1?
Reconstitution should occur under sterile laminar flow using bacteriostatic water or sterile PBS (pH 7.4). Gently swirl the vial until dissolved completely; do not vortex or shake aggressively.
How does melanotan1 differ structurally from native α-MSH?
Melanotan1 replaces Met4 with Norleucine (Nle4) and L-Phe7 with D-Phenylalanine (D-Phe7). These substitutions confer resistance against enzymatic degradation, extending its half-life during in vitro assays.
How does melanotan1 compare to Melanotan II?
Melanotan1 is a linear peptide with higher selectivity for the MC1R subtype, whereas Melanotan II is a cyclic peptide that readily crosses the blood-brain barrier and demonstrates potent cross-reactivity with central MC3R and MC4R receptors.
Does PX1 Research provide a Certificate of Analysis (COA) with melanotan1?
Yes. Every single lot of melanotan1 includes a downloadable, lot-specific COA generated by an independent ISO 17025 accredited laboratory detailing RP-HPLC and MS analytical results.
What are the shipping and handling timelines for melanotan1 orders?
PX1 Research dispatches orders same-day Monday through Friday from facilities located in California and Arizona, ensuring minimal transit times for research laboratories nationwide.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.